Lethal Clostridium difficile Colitis Associated with Paclitaxel and Carboplatin Chemotherapy in Ovarian Carcinoma: Case Report and Review of the Literature

por Masciullo, V., Mainenti, S., Lorusso, D., Margariti, P. A., Scambia, G.
Publicado 2010

The Role of Secondary Surgery in Recurrent Ovarian Cancer

por Lorusso, D., Mancini, M., Di Rocco, R., Fontanelli, R., Raspagliesi, F.
Publicado 2012

Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer

por D'Agostino, G, Ferrandina, G, Ludovisi, M, Testa, A, Lorusso, D, Gbaguidi, N, Breda, E, Mancuso, S, Scambia, G
Publicado 2003

Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary

por Mangili, G, Ottolina, J, Gadducci, A, Giorda, G, Breda, E, Savarese, A, Candiani, M, Frigerio, L, Scarfone, G, Pignata, S, Rossi, R, Marinaccio, M, Lorusso, D
Publicado 2013

Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II study

por Adamo, V, Lorusso, V, Rossello, R, Adamo, B, Ferraro, G, Lorusso, D, Condemi, G, Priolo, D, Di Lullo, L, Paglia, A, Pisconti, S, Scambia, G, Ferrandina, G
Publicado 2008

Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in Italy

por Berardi, R., Torniai, M., Cona, M.S., Cecere, F.L., Chiari, R., Guarneri, V., La Verde, N., Locati, L., Lorusso, D., Martinelli, E., Giannarelli, D., Garassino, M.C.
Publicado 2021

A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1...

por Pignata, S, Scambia, G, Pisano, C, Breda, E, Di Maio, M, Greggi, S, Ferrandina, G, Lorusso, D, Zagonel, V, Febbraro, A, Riva, N, De Rosa, V, Gallo, C, Perrone, F
Publicado 2007

Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?

por Musacchio, L., Cicala, C.M., Camarda, F., Ghizzoni, V., Giudice, E., Carbone, M.V., Ricci, C., Perri, M.T., Tronconi, F., Gentile, M., Salutari, V., Scambia, G., Lorusso, D.
Publicado 2022

Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients

por Lorusso, D, Scambia, G, Amadio, G, di Legge, A, Pietragalla, A, De Vincenzo, R, Masciullo, V, Di Stefano, M, Mangili, G, Citterio, G, Mantori, M, Lambiase, A, Bordignon, C
Publicado 2012

Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with ref...

por Ochsenreither, S., Fiedler, W.M., Conte, G.D., Macchini, M., Matos, I., Habel, B., Ahrens-Fath, I., Raspagliesi, F., Lorusso, D., Keilholz, U., Rolling, C., Kebenko, M., Klinghammer, K.F., Saavedra, O., Baumeister, H., Zurlo, A., Garralda, E.
Publicado 2022

Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer

por Koppikar, S., Oaknin, A., Babu, K. Govind, Lorusso, D., Gupta, S., Wu, L.-Y., Rajabto, W., Harano, K., Hong, S.-H., Malik, R.A., Strebel, H., Aggarwal, I.M., Lai, C.-H., Dejthevaporn, T., Tangjitgamol, S., Cheng, W.F., Chay, W.Y., Benavides, D., Hashim, N.M., Moon, Y.W., Yunokawa, M., Anggraeni, T.D., Wei, W., Curigliano, G., Maheshwari, A., Mahantshetty, U., Sheshadri, S., Peters, S., Yoshino, T., Pentheroudakis, G.
Publicado 2023

Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial

por Capoluongo, E.D., Pellegrino, B., Arenare, L., Califano, D., Scambia, G., Beltrame, L., Serra, V., Scaglione, G.L., Spina, A., Cecere, S.C., De Cecio, R., Normanno, N., Colombo, N., Lorusso, D., Russo, D., Nardelli, C., D’Incalci, M., Llop-Guevara, A., Pisano, C., Baldassarre, G., Mezzanzanica, D., Artioli, G., Setaro, M., Tasca, G., Roma, C., Campanini, N., Cinieri, S., Sergi, A., Musolino, A., Perrone, F., Chiodini, P., Marchini, S., Pignata, S.
Publicado 2022